Pharmacokinetic study of aldoxorubicin in patients with solid tumors

Conclusions Our findings support dosing and administration schemas used in an ongoing phase 3 clinical study of aldoxorubicin in soft tissue sarcoma, and phase 2 clinical studies in small cell lung cancer, glioblastoma, and Kaposi’s sarcoma.
Source: Investigational New Drugs - Category: Drugs & Pharmacology Source Type: research